Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Trading and strategy update

19 Jun 2018 07:00

RNS Number : 7840R
McCarthy & Stone PLC
18 June 2018
 

18 June 2018

McCARTHY & STONE PLC

Trading Update

McCarthy & Stone is today issuing the following trading update ahead of reporting its final results for the year ending 31 August 2018.

 

2018 Financial Performance

 

On 11 April, the Group reported a good response to the opening of its new sales outlets during Q1 of the calendar year. Since this date, however, there has been a noticeable decline in reservation rates as potential customers have exercised more caution due to ongoing economic uncertainty, a slower secondary market and a softening of pricing, particularly in the South East. 

 

The Group's outcome for the financial year ending 31 August 2018 was always heavily dependent on a strong Spring selling season, and under these less favourable conditions the Group is now forecasting to achieve c.2,100 to c.2,300 (2017: 2,302) legal completions. As a result, the Group is now guiding to an expected FY18 operating profit of £65m to £80m (FY17: £96m), with the profit impact of the unit shortfall skewed to the South (at higher average selling prices). The Group's forward order book including legal completions currently stands c. £67m ahead of the prior year at £706m (2017: £639m). Whilst this is lower than management's expectations given the higher number of outlets, it is nevertheless sufficient to deliver within the new guided range. Incentives and discounts are also expected to remain approximately in line with recent prior year levels. 

 

The contract for the sale of the Group's H2 Freehold Reversionary Interests has now exchanged with a total cash value of c.£30m and completion expected prior to the year end in August.

 

Throughout the period, the Group has continued to exercise its usual cash management discipline with the overriding priority of maintaining a strong balance sheet. At year end, any debt is likely to be at a low level and we are forecasting a FY18 TNAV of c.£700m.

 

Future strategy

 

The growing need for retirement housing caused by the UK's rapidly ageing population continues to underpin the long-term prospects of McCarthy & Stone. The business has consistently achieved five star customer satisfaction scores (2018: 93.5% recommend score) supported by its industry-leading levels of build quality.

 

However, in light of the ongoing difficult market conditions, and without the benefit of any additional Government support for the retirement housing sector, the Group began a review of its strategy in April led by the Chairman, Paul Lester.

 

This strategic review will seek to focus on improving margins and ROCE (targeting mid-teens ROCE over the short to medium term) together with a more balanced workflow. This will naturally lead to a more measured growth trajectory and a right-sizing of the Group's cost base, with build cost savings as an additional key area of focus. As outlined in its half year results presentation, McCarthy & Stone will also be trialling a number of strategic initiatives designed to increase customer appeal and offer a broader choice of tenure options including rental and part ownership.

 

Whilst the focus currently remains on delivering the best possible result for the year end, the Group will provide a further update on the actions resulting from this strategic review in September.

 

The Board has announced separately this morning that Clive Fenton will retire as Chief Executive and step down from the Board on 31 August. A search to identify his successor has commenced.

Paul Lester, Chairman, Clive Fenton, Chief Executive Officer and Rowan Baker, Chief Financial Officer, will be hosting a conference call for analysts and investors at 8.00am today, Tuesday 19 June, to discuss this trading update. If you wish to participate in the call please contact Powerscourt on 020 7250 1446.

 

This announcement contains inside information as defined in the Market Abuse Regulation (EU) 596/2014

 

- Ends -

 

 

For more information, please contact:

 

McCarthy & Stone, 01202 292480

Paul Lester, Chairman

Clive Fenton, Chief Executive Officer

Rowan Baker, Chief Financial Officer

Paul Teverson, Director of Communications

 

Powerscourt, 020 7250 1446 / mccarthy-stone@powerscourt-group.com

Justin Griffiths

Nick Dibden

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGURUQUPRPPR
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.